Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · fourth_quarter · Health Issues
SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40); CMS Physician Fee Schedule CY25 Proposed Rule (RIN #0938-AV33);Continuing appropriations for FY25 (HR 9747, HR 10545)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2024 · fourth_quarter · Pharmacy
Issues related to overdose reversal products; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; H.R.8070/S.4638, National Defense Authorization Act for Fiscal Year 2025, issues related to Naloxone; H.R.10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40); CMS Physician Fee Schedule CY25 Proposed Rule (RIN #0938-AV33)
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2024 · third_quarter · Pharmacy
Issues related to overdose reversal products; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; H.R.8070/S.4638, National Defense Authorization Act for Fiscal Year 2025, issues related to Naloxone.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY24 Further Consolidated Appropriations Act (HR 2882), FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40)
Client expense: $260,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2024 · second_quarter · Pharmacy
Issues related to overdose reversal products; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations process; FY2025 National Defense Authorization Act (H.R.8070), issues related to Naloxone.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Pharmacy
Issues related to overdose reversal products; H.R.2617, Consolidated Appropriations Act, 2023 (P.L.117-328) implementation; FY2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, S.2624/H.R.5894; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations process.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
FY24 Labor-HHS-Education (HR 5894 / S 2624), Military Construction & Veterans Affairs (HR 4366 / S 2127) and Commerce-Justice-Science (HR 5893 / S 2321) Appropriations; SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY24 Further Consolidated Appropriations Act (HR 2882), FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science
Client expense: $270,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · fourth_quarter · Health Issues
FY24 Labor-HHS-Education (HR 5894 / S 2624), Military Construction & Veterans Affairs (HR 4366 / S 2127) and Commerce-Justice-Science (HR 5893 / S 2321) Appropriations; SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971)
Client expense: $270,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · fourth_quarter · Pharmacy
Issues related to overdose reversal products; H.R.2617, Consolidated Appropriations Act, 2023 (P.L.117-328) implementation; FY2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, S.2624/H.R.5894; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · third_quarter · Health Issues
FY24 Labor-HHS-Education (HR 5894 / S 2624), Military Construction & Veterans Affairs (HR 4366 / S 2127) and Commerce-Justice-Science (HR 5893 / S 2321) Appropriations; SUPPORT Act of 2023 (HR 4531 / S 2433); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971)
Client expense: $280,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · third_quarter · Health Issues
Affordability is Access Act HR 3589/S 1698 Right to Contraception Act HR 4121/S 1999 Black Maternal Health Momnibus HR 3305/S 1606 Enhancing Questions to Understand Intentions for Pregnancy (EQUIP) Act HR 3659 Anti-Racism in Public Health Act HR 2904/S 1317 Establishing Office of Sexual and Reproductive Health HR 4281 Resolution Opposing Criminalization of People Seeking Essential Health Care H Res 561 Convenient Contraception Act HR 4816 / S 2427 Reproductive Health Care Accessibility Act HR 4901 / S 2544 HEAL Act HR 4007 / S 2809 World Contraception Day Resolution H Res 68
Client expense: $22,842 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE